Patient Parameters

Patient Identifier / MRN

Age (years)

Sex

Height

Actual Body Wt

Ideal Body Wt

BSA Dosing Weight (default: Actual — per ASCO obesity-dosing guideline)

BSA Cap

⚠ BSA caps are institutional/protocol-specific — not a global standard. "No cap" is correct for most regimens unless your protocol or PI explicitly mandates one. Verify before applying.

Laboratory Values

SCr (mg/dL)

Apply SCr floor (min 0.7 mg/dL) for
sarcopenic/elderly patients Prevents carboplatin overdose from artificially low SCr

ANC (/µL)

Platelets (K/µL)

Hemoglobin

AST (U/L)

ALT (U/L)

T. Bili (mg/dL)

Alk Phos (U/L)

Albumin (g/dL)

Na (mEq/L)

K (mEq/L)

Mg (mg/dL)

Glucose (mg/dL) EV ⚠

WBC (K/µL)

LVEF (%)

Cycle #

Prior AUC (carbo)

Regimen Selection

I confirm this tool is for verification support only and does not replace independent clinical judgment, current PI review, or institutional protocol. Results require pharmacist sign-off.

Dose Reduction (MD-Ordered)

% 0 = full dose
e.g. 20 = 20% dose reduction

⚠ Cumulative Dose History

Prior Anthracycline
(mg/m² doxorubicin equiv.)

Prior Bleomycin
(units)

Prior Oxaliplatin
(mg/m² cumulative — neuropathy risk >500)

Anthracycline lifetime limit: 450–550 mg/m² (doxorubicin) · Bleomycin: ~400 units · Oxaliplatin neuropathy risk: >500 mg/m²

⬡

SELECT A REGIMEN AND ENTER PATIENT PARAMETERS

All calculations per pharmacist verification workflow